<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05036941</url>
  </required_header>
  <id_info>
    <org_study_id>APM/AM/001</org_study_id>
    <nct_id>NCT05036941</nct_id>
  </id_info>
  <brief_title>A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW)</brief_title>
  <official_title>A Cluster Randomized Trial of Two Mask Systems (Acteev™ N95 + Acteev™ Fabric Masks vs. Standard N95 + Fabric Masks During Shifts &amp; in Community) in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) in HCWs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ascend Performance Materials</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jehangir Clinical Development Centre Pvt. Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ascend Performance Materials</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cluster randomized trial will be conducted to evaluate the difference between an Acteev™&#xD;
      system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community) and a&#xD;
      standard system (standard N95 masks during shifts+ fabric masks in community) in preventing&#xD;
      Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2)in healthcare workers(HCWs).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a maximum 10-week (8-week intervention+2-week follow up) (with the option of&#xD;
      extending for another 4 weeks if needed) two-armed controlled study to investigate efficacy&#xD;
      of Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in&#xD;
      community) compared with standard system (standard N95 masks during shifts+ fabric masks in&#xD;
      community) in HCWs working in high-risk hospital wards (ICU, emergency), against the&#xD;
      prevention of SARS CoV-2 infection. Prospective HCWs will be identified for the study by the&#xD;
      study investigator/study team and be invited for participation in the study. All study&#xD;
      procedures will begin only after obtaining written informed consent from the subjects.&#xD;
      Subjects will be randomized in one of the two arms mentioned below after meeting all the&#xD;
      study eligibility criteria: Arm 1:Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+&#xD;
      Acteev™ fabric masks in community) Arm 2: Standard system (standard N95 masks during shifts+&#xD;
      fabric masks in community).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The efficacy of Acteev™ system vs standard system in preventing SARS CoV-2 infection in health care workers</measure>
    <time_frame>8 weeks of wearing the masks (with the option of increasing to 12 weeks) with 2 weeks of following up.</time_frame>
    <description>• Number of cases with laboratory-confirmed for viral SARS CoV 2 respiratory infection using RT-PCR with or without two or more respiratory symptoms or one respiratory symptom and/or a systemic symptom</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The efficacy of Acteev™ system vs standard system in preventing CRI/ILI infection in healthcare workers</measure>
    <time_frame>8 weeks of wearing the masks (with the option of increasing to 12 weeks) with 2 weeks of following up</time_frame>
    <description>• Number of cases with Clinical Respiratory illness defined as two or more respiratory symptoms or one respiratory symptom and/or a systemic symptom along with laboratory-confirmed viral and bacterial respiratory infection other than SARS CoV 2 (Including respiratory syncytial virus (RSV), human metapneumovirus(hMPV), influenza A (H3N2), (H1N1) pdm09, influenza B, parainfluenza viruses 1-4, influenza C, rhinoviruses, severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV), coronaviruses 229E, NL63,OC43 and HKU1, adenoviruses and Bacteria like Bordetella pertussis, Bordetella parapertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>SARS CoV-2 Infection</condition>
  <condition>Influenza -Like Illness</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard system (standard N95 masks during shifts+ fabric masks in community)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acteev™ Masks</intervention_name>
    <description>Participants will wear the mask on every shift for 8 or 12 consecutive weeks. Participants in Arm 1 will be supplied adequate number of Acteev™ N95 masks YQD8008 during 8-hour shift and Acteev™ fabric masks for community use.</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comparison Masks</intervention_name>
    <description>Participants will wear the mask on every shift for 8 or 12 consecutive weeks. Participants in Arm 2 will be supplied with adequate number of standard N95 masks during 8-hour shift and fabric mask for community use.</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Health care workers and allied health care staff working in COVID wards, COVID ICU,&#xD;
             Non COVID ICU (This will include all specialty ICUs in the hospital),&#xD;
             Casualty/Emergency, Operation Theatre and Pathology lab of the hospital&#xD;
&#xD;
          -  Health care workers and allied health care staff involved in performing high risk&#xD;
             procedures like suctioning, intubation, nebulized medications, chest physiotherapy,&#xD;
             other aerosol generating procedures and handling pathology samples&#xD;
&#xD;
          -  Negative COVID 19 RT-PCR test within last 3 days of screening&#xD;
&#xD;
          -  COVID 19 vaccinated or non-vaccinated&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable or refused to consent&#xD;
&#xD;
          -  Current respiratory illness, rhinitis and/or allergy&#xD;
&#xD;
          -  Currently participating in any other clinical trial&#xD;
&#xD;
          -  Beard or facial hair&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raina MacIntyre, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New South Wales, Sydney, AUSTRALIA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vikram Gopal, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ascend Performance Materials</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yantao Z Hughes, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ascend Performance Materials</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neelambari Bhosale</last_name>
    <phone>+91-9823783443</phone>
    <email>neelambari@jcdc.co.in</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pathik Divate</last_name>
    <phone>+91-9325668979</phone>
    <email>pathik@jcdc.co.in</email>
  </overall_contact_backup>
  <reference>
    <citation>MacIntyre CR, Seale H, Dung TC, Hien NT, Nga PT, Chughtai AA, Rahman B, Dwyer DE, Wang Q. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open. 2015 Apr 22;5(4):e006577. doi: 10.1136/bmjopen-2014-006577.</citation>
    <PMID>25903751</PMID>
  </reference>
  <reference>
    <citation>Narayan VV, Iuliano AD, Roguski K, Bhardwaj R, Chadha M, Saha S, Haldar P, Kumar R, Sreenivas V, Kant S, Bresee J, Jain S, Krishnan A. Burden of influenza-associated respiratory and circulatory mortality in India, 2010-2013. J Glob Health. 2020 Jun;10(1):010402. doi: 10.7189/jogh.10.010402.</citation>
    <PMID>32373326</PMID>
  </reference>
  <reference>
    <citation>Chavan RD, Kothari ST, Zunjarrao K, Chowdhary AS. Surveillance of acute respiratory infections in Mumbai during 2011-12. Indian J Med Microbiol. 2015 Jan-Mar;33(1):43-50. doi: 10.4103/0255-0857.148376.</citation>
    <PMID>25560001</PMID>
  </reference>
  <reference>
    <citation>Mudhigeti N, Racherla RG, Mahalakshmi PA, Pamireddy ML, Nallapireddy U, Kante M, Kalawat U. A study of influenza 2017-2018 outbreak in Andhra Pradesh, India. Indian J Med Microbiol. 2018 Oct-Dec;36(4):526-531. doi: 10.4103/ijmm.IJMM_18_272.</citation>
    <PMID>30880701</PMID>
  </reference>
  <reference>
    <citation>Gopal V, Nilsson-Payant BE, French H, et al. Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus. Preprint. bioRxiv. 2020;2020.11.02.365833. Published 2020 Nov 4. doi:10.1101/2020.11.02.365833</citation>
  </reference>
  <reference>
    <citation>MacIntyre CR, Wang Q, Cauchemez S, Seale H, Dwyer DE, Yang P, Shi W, Gao Z, Pang X, Zhang Y, Wang X, Duan W, Rahman B, Ferguson N. A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir Viruses. 2011 May;5(3):170-9. doi: 10.1111/j.1750-2659.2011.00198.x. Epub 2011 Jan 27.</citation>
    <PMID>21477136</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 26, 2021</study_first_submitted>
  <study_first_submitted_qc>September 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2021</study_first_posted>
  <last_update_submitted>September 11, 2021</last_update_submitted>
  <last_update_submitted_qc>September 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Clinical respiratory illness (CRI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

